tiprankstipranks
Arbutus Biopharma Corporation (ABUS)
NASDAQ:ABUS

Arbutus Biopharma (ABUS) Stock Investors

1,166 Followers
Based on 732,069 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ABUS
On average, investors allocate 4.27% of their portfolios to ABUS
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 732,069 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ABUS

1.5%
Last 7
Days
3.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ABUS, out of 732,069 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ABUS Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Reduced
0.02%
$1.67
Based on the activity of 13,753 investors who made their portfolios public
The table shows changes in ABUS in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ABUS Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Arista Networks
4.19%
-0.51%
-1.97%
82.12B
Technology
Block
4.40%
-0.05%
-2.81%
43.28B
Technology
Riot Platforms
5.04%
-0.19%
+3.18%
2.97B
Financial
Tilray
3.83%
-1.03%
-4.02%
1.56B
Healthcare
Marathon Digital Holdings
5.49%
-1.01%
-0.77%
4.82B
Financial
GE Aerospace
5.50%
+0.23%
+8.44%
178.03B
Industrials
Salesforce
4.92%
-0.18%
+4.58%
263.97B
Technology
AMC Entertainment
5.46%
-1.54%
-4.16%
865.10M
Communication Services
Micron
5.67%
+0.04%
+4.86%
124.39B
Technology
Qualcomm
4.94%
+1.72%
+0.67%
200.99B
Technology
Based on the activity of 732,069 active portfolios
Open your Smart Portfolio

ABUS Investor Analysis

ABUS investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
9.1%
of ABUS holders
are under 35
Average Segment Performance
Average P/E Ratio56.32
Beta6.59
Dividend Yield6.13%
ABUS investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
53.7%
of ABUS holders
are between 35–55
Average Segment Performance
Average P/E Ratio61.35
Beta11.34
Dividend Yield17.67%
ABUS investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
37.2%
of ABUS holders
are over 55
Average Segment Performance
Average P/E Ratio52.26
Beta4.21
Dividend Yield22.32%
Overview of age group and performance of ABUS stock investors
See who invests in ABUS according to age group and performance.

FAQ

How many retail Investors hold ABUS?
<0.1% of TipRanks' retail investors hold ABUS in their portfolios.
    What is ABUS Investor Sentiment?
    ABUS’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of ABUS in the last 7 days?
      ▼ 1.5% of TipRanks' retail investors changed their holding of ABUS in the last 7 days.
        What percentage of retail investors changed their holding of ABUS in the last 30 days?
        ▼ 3.1% of TipRanks' retail investors changed their holding of ABUS in the last 30 days.
          What is the average age of retail investors who hold ABUS?
          The average age of ABUS Holders is between 35–55.
            What other stocks have ABUS investors also bought?
            ABUS Investors also bought ANET, SQ, RIOT, TLRY, MARA, GE, CRM, AMC, MU, QCOM.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              ARAYAccuray
              BAXBaxter International
              BDXBecton Dickinson
              BMRNBioMarin Pharmaceutical
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis